Mar­ket­ingRx roundup: Genen­tech, Bris­tol My­ers lead Fast Com­pa­ny in­no­va­tors list; Re­al Chem­istry inks AI deal  

Genen­tech in the biotech cat­e­go­ry and Bris­tol My­ers Squibb in the phar­ma­ceu­ti­cal cat­e­go­ry notched top spots on Fast Com­pa­ny’s an­nu­al best work­places for in­no­va­tors list for 2023. Oth­er biotechs on the list were Roivant Sci­ences and Akadeum Life Sci­ences, while on the phar­ma side, Alyny­lam and an­i­mal health spe­cial­ist Zoetis were both named.

The pub­li­ca­tion not­ed Genen­tech’s new $250 mil­lion man­u­fac­tur­ing in­vest­ment in San Fran­cis­co for small-batch drug pro­duc­tion for clin­i­cal tri­als in its write­up, and point­ed up Roivant’s promis­ing two-year pro­gram for re­cent grad­u­ates.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER